ALLR
Price
$1.69
Change
-$0.06 (-3.43%)
Updated
Oct 8, 12:19 PM (EDT)
Capitalization
25.42M
NRXP
Price
$3.54
Change
-$0.13 (-3.54%)
Updated
Oct 8, 12:40 PM (EDT)
Capitalization
79.63M
Interact to see
Advertisement

ALLR vs NRXP

Header iconALLR vs NRXP Comparison
Open Charts ALLR vs NRXPBanner chart's image
Allarity Therapeutics
Price$1.69
Change-$0.06 (-3.43%)
Volume$848
Capitalization25.42M
NRX Pharmaceuticals
Price$3.54
Change-$0.13 (-3.54%)
Volume$229
Capitalization79.63M
ALLR vs NRXP Comparison Chart in %
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLR vs. NRXP commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLR is a Hold and NRXP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (ALLR: $1.75 vs. NRXP: $3.67)
Brand notoriety: ALLR and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLR: 5% vs. NRXP: 138%
Market capitalization -- ALLR: $25.42M vs. NRXP: $79.63M
ALLR [@Biotechnology] is valued at $25.42M. NRXP’s [@Biotechnology] market capitalization is $79.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLR’s FA Score shows that 2 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • ALLR’s FA Score: 2 green, 3 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, ALLR is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLR’s TA Score shows that 3 TA indicator(s) are bullish while NRXP’s TA Score has 6 bullish TA indicator(s).

  • ALLR’s TA Score: 3 bullish, 3 bearish.
  • NRXP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NRXP is a better buy in the short-term than ALLR.

Price Growth

ALLR (@Biotechnology) experienced а +10.76% price change this week, while NRXP (@Biotechnology) price change was +11.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.37%. For the same industry, the average monthly price growth was +18.22%, and the average quarterly price growth was +86.47%.

Industries' Descriptions

@Biotechnology (+8.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($79.6M) has a higher market cap than ALLR($25.4M). NRXP has higher P/E ratio than ALLR: NRXP (0.36) vs ALLR (0.30). NRXP YTD gains are higher at: 66.818 vs. ALLR (49.573). ALLR has higher annual earnings (EBITDA): -24.25M vs. NRXP (-33.79M). ALLR has more cash in the bank: 17.8M vs. NRXP (2.91M). ALLR has less debt than NRXP: ALLR (1.38M) vs NRXP (10.2M). ALLR (0) and NRXP (0) have equivalent revenues.
ALLRNRXPALLR / NRXP
Capitalization25.4M79.6M32%
EBITDA-24.25M-33.79M72%
Gain YTD49.57366.81874%
P/E Ratio0.300.3685%
Revenue00-
Total Cash17.8M2.91M612%
Total Debt1.38M10.2M13%
FUNDAMENTALS RATINGS
NRXP: Fundamental Ratings
NRXP
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLRNRXP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 7 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ALLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.160.05
+2.37%
CytoMed Therapeutics Limited
TRDA5.85-0.07
-1.18%
Entrada Therapeutics
BCPC141.18-1.98
-1.38%
Balchem Corp
CMG40.95-0.68
-1.63%
Chipotle Mexican Grill
FOXF23.46-0.65
-2.70%
Fox Factory Holding Corp

ALLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLR has been closely correlated with TAOX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALLR jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLR
1D Price
Change %
ALLR100%
+6.06%
TAOX - ALLR
87%
Closely correlated
-6.36%
AGEN - ALLR
87%
Closely correlated
+2.41%
RNAC - ALLR
86%
Closely correlated
-2.60%
NCNA - ALLR
86%
Closely correlated
+38.19%
NRXP - ALLR
81%
Closely correlated
+9.55%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+9.55%
RNAC - NRXP
86%
Closely correlated
-2.60%
NCNA - NRXP
85%
Closely correlated
+38.19%
TAOX - NRXP
84%
Closely correlated
-6.36%
ALLR - NRXP
81%
Closely correlated
+6.06%
PALI - NRXP
74%
Closely correlated
-11.81%
More